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The presence of semen in vaginal ﬂuid, as identiﬁed by an acid phosphatase spot test, does not inﬂuence vaginal proinﬂammatory
cytokine concentrations. Objective: determine whether semen, as detected by acid phosphatase, inﬂuences vaginal cytokines or
secretory leukocyte protease inhibitor concentrations. Methods: 138 pregnant women had vaginal ﬂuid collected for Gram stain,
acid phosphatase detection by colorimetric assay, and interleukin 1-Beta, interleukin-6, interleukin-8, and secretory leukocyte
protease inhibitor measurement by enzyme immunoassay. Results for women with and without acid phosphatase were compared
by Mann-Whitney test. Results: of 138 subjects, 28 (20%) had acid phosphatase detected; of these, only 19 (68%) reported recent
intercourse and 3 (11%) had sperm seen on Gram stain. There were no signiﬁcant diﬀerences in proinﬂammatory cytokine
concentrations; however, secretory leukocyte protease inhibitor concentrations were signiﬁcantly higher among women with acid
phosphatase. Conclusions: proinﬂammatory cytokine measurement does not appear to be aﬀected by the presence of semen, but
secretory leukocyte protease inhibitor is signiﬁcantly higher when semen is present. Detection of semen by acid phosphatase
was associated with higher vaginal SLPI concentrations, however, the presence of semen did not appear to inﬂuence vaginal
proinﬂammatory cytokine concentrations.
Copyright © 2008 Kathy J. Agnew et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Bacterialvaginosis(BV)isacommonconditioncausingvari-
ous symptoms such as vaginal discharge, odor and irritation,
and has been associated with increased acquisition of many
sexually transmitted diseases [1, 2]. Pregnant women with
BV have an increased risk of preterm labor and preterm
delivery with the potential for neonatal morbidity and
mortality[3].EarlyresearchconcerningBVcharacterizedthe
vaginal microbiological ﬂora using Gram stain and culture
[4, 5]. More recent studies have focused on host defense
factors and the local immune response that may mediate the
relationship between vaginal ﬂora and adverse reproductive
and pregnancy outcomes [6, 7]. Proinﬂammatory cytokines
such as interleukin 1-Beta (IL-1β), interleukin 6 (IL-6),
interleukin 8 (IL-8), and the host defense molecule secretory
leukocyte protease inhibitor (SLPI) have been of particular
interest [8–10].
Subjects are routinely asked to avoid vaginal intercourse
and the use of intravaginal products that might aﬀect test
results prior to having specimens collected. However, com-
pliancewiththeserequestsisdiﬃculttoassess.Whenvaginal
ﬂuid is collected to measure cytokine concentrations, it is
important to determine what eﬀect, if any, there may be on
the results if semen is present. The objective of this analysis
was to determine whether semen present in vaginal ﬂuid
alters proinﬂammatory cytokine or SLPI concentrations. We
hypothesized that the presence of semen would increase the
concentrations of vaginal proinﬂammatory cytokines and
SLPI.2 Infectious Diseases in Obstetrics and Gynecology
2. MATERIALS AND METHODS
This secondary analysis included data from 138 pregnant
women, between 7 and 20 weeks gestation, who participated
in a prospective observational cohort study of the eﬀects of
BV on pregnancy outcome. Subjects were recruited from the
prenatal clinics associated with the University of Washington
Medical Center in Seattle, Wash, USA. Participation in the
study was limited to those subjects who met the following
criteria: singleton pregnancy less than 20 weeks gestation,
no prior preterm birth or major medical problems such as
chronic hypertension or pre-existing diabetes, and no recent
antibiotic use. The study was approved by the University
of Washington and the Centers for Disease Control and
Prevention Institutional Review Boards and all subjects
provided written, informed consent.
The data for the present analysis were taken from study
entry visit. We compared subject history, Gram stain for
sperm and detection of acid phosphatase as predictors for
the presence of semen in vaginal ﬂuid. Acid phosphatase
was considered to be the reference as it is an enzyme
present in high concentrations in semen, but not found in
other secretions such as vaginal ﬂuid, saliva, or mucus [11].
We then compared the concentrations of proinﬂammatory
cytokines and SLPI in samples from women with and
without semen detected in vaginal ﬂuid.
Subjects were asked to abstain from vaginal intercourse
and the use of intravaginal products for 48 hours prior
to their study visit. Subjects completed a structured inter-
view with questions regarding demographics, reproductive
history, behavioral habits, and time of last intercourse. A
physical exam was conducted including notation of Amsel
criteria [12] as well as a vaginal wet mount and Gram stain.
Two Dacron swabs were used to collect vaginal ﬂuid
from the posterior vaginal fornix and placed in cryotubes
containing 0.9mL phosphate buﬀered saline. Swabs were
frozen at −80 degrees and stored for later cytokine and
SLPI testing. An additional Dacron swab was used to collect
vaginal ﬂuid to prepare an air-dried microscope slide which
was then Gram stained and read at 100X magniﬁcation
for the presence of semen and determination of BV score
by Nugent criteria [13]. Vaginal ﬂuid from the frozen
sampleswasaliquotedandusedtomeasureproinﬂammatory
cytokine and SLPI concentrations by enzyme immunoassay
[14]. For acid phosphatase detection, vaginal ﬂuid was
spotted to Whatman no.1 ﬁlter paper and then placed in
a chemical fume hood and sprayed until wet with the
prepared reagent. Development of a purple color within 1
minute was considered a positive test for the presence of acid
phosphatase [15, 16]. The reagent was prepared by mixing
10mL of stock solution A (1 gram Fast Blue B, 20 grams
sodium acetate trihydrate, 10mL glacial acetic acid, 100mL
dH20) and 1.0mL of stock solution B (0.4 grams sodium
alpha naphthyl acid phosphate, 5mL dH20) in a spray bottle.
The prepared reagent has a shelf life of 7 days, while stock
solutionsAandBarestableforuptosixmonthsat4degrees.
We used the Chi square test or Fisher’s exact test for
categorical variables. The Mann-Whitney test was used for
continuous variables. Analyses were stratiﬁed by presence or
absence of BV on Gram stain, given that proinﬂammatory
cytokines and SLPI may vary with BV status [17, 18].
3. RESULTS
Of 138 subjects, 36 (26%) reported vaginal intercourse
within the past two days, despite instructions to abstain.
28 (20%) had acid phosphatase detected in their vaginal
ﬂuid, and 6 (4%) had sperm seen on Gram stain. Women
with detectable acid phosphatase were more likely than
those without acid phosphatase to report recent vaginal
intercourse (68% versus 15%, P<. 0001), yet subject history
and acid phosphatase detection did not have high concor-
dance. Subjects with and without detectable semen by acid
phosphatase were similar with respect to age, race/ethnicity,
gestational age, and presence of genital infections (see
Table 1).
The remaining analyses compared vaginal cytokine and
SLPI concentrations among women with and without acid
phosphatase detected in vaginal ﬂuid. There was no sig-
niﬁcant diﬀerence in IL-1β, IL-6, or IL-8 concentrations
among women with or without acid phosphatase, when
stratiﬁed for BV (see Figures 1(a), 1(b), 1(c)). However,
SLPI concentrations were signiﬁcantly higher in the acid
phosphatase positive group regardless of BV status (see
Figure 1(d)).
There was a signiﬁcant increase in IL-1β and decrease in
SLPI among women with BV (see Figures 1(a), 1(d))
4. DISCUSSION
Inthiscohortofpregnantwomen,detectionofsemenbyacid
phosphatase was associated with higher SLPI concentrations
in vaginal ﬂuid. These results are not surprising, in that SLPI
is a known component of seminal ﬂuid, [19] however, the
presence of semen did not appear to inﬂuence the vaginal
proinﬂammatory cytokine concentrations. Proinﬂammatory
cytokines can also be detected in semen but are usually
not present at high concentrations except in the context
of a sexually transmitted infection in the male partner.
Increased cytokine levels in semen have been established in
HIV infection (IL-1β), [20] and genital infections such as
Chlamydia trachomatis (IL-8) [21]a n dNeisseria gonorrhoeae
(IL-6, IL-8) [22].
We did ﬁnd a high (26%) prevalence of recent vaginal
intercourse by history, despite instructions to abstain prior
to the study visit. We also found that patient history is not a
highly sensitive or speciﬁc marker for the detection of acid
phosphatase, as only 68% of those with acid phosphatase
present reported recent intercourse. Gram stain detection
of sperm is limited by the concentration of sperm as well
as duration of persistence in the vaginal ﬂuid. In addition,
we found that Gram stain is not a useful method to screen
for recent vaginal intercourse, with a sensitivity of only
11%. While other tests such as prostate speciﬁc antigen
(PSA) may be more sensitive, the cost and implementation
of equipment and methodology to perform this ELISA test
may be prohibitive to many laboratories. It is necessary to
note that while samples were immediately frozen for storageKathy J. Agnew et al. 3
Table 1: Subject characteristics by acid phosphatase.
Subject characteristics Acid phosphatase + n = 28 Acid phosphatase −n = 110
Age (median) 27 26
Race/Ethnicity
White 11 (42) 43 (39)
African American 1 (4) 22 (20)
Hispanic 8 (31) 15 (14)
Asian 4 (15) 22 (20)
Other/unknown 2 (7) 8 (7)
Gestational age (median weeks) 16 16
Bacterial vaginosis 18 (64) 51 (46)
Trichomonas vaginalis 1 (4) 1 (10)
Chlamydia trachomatis ∗∗ 1( 5 ) 3( 3 )
Neisseria gonorrhoeae 0 (0) 0 (0)
Self-reported vaginal intercourse 19 (68) 17 (15)
Sperm on Gram stain 3 (11) 3 (3)
∗All data are presented as n (%) unless otherwise noted.
∗∗n = 21 for AP + group, n = 91 for AP − group.
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Figure 1: Comparison of vaginal cytokine and secretory leukocyte protease inhibitor concentrations by presence or absence of acid
phosphatase and bacterial vaginosis.4 Infectious Diseases in Obstetrics and Gynecology
after collection and care taken to minimize the number
of freeze/thaw cycles when aliquoting for testing, we can
not determine if there was any degradation of cytokine
concentrations over time or due to the presence of semen.
Also our ﬁndings may not be generalizable to a nonpregnant
population.
Results from this study suggest that the use of acid
phosphatase to detect semen in vaginal ﬂuid samples can
provideusefulinformationandthistestingcanbeperformed
using a simple and inexpensive method. Vaginal ﬂuid sam-
ples with acid phosphatase should not have SLPI measured,
as there is likely a substantial contribution from seminal
ﬂuid. However, measurement of proinﬂammatory cytokines
is probably not inﬂuenced by the presence of semen. The
acid phosphatase detection test may be a useful adjunct for
analysis of the eﬀect of seminal ﬂuid on other host defense
and immune factors in future studies.
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